Definitive Healthcare special committee reviews Advent non-binding $1.02-per-share go-private proposal

 

Definitive Healthcare special committee reviews Advent's non-binding $1.02-per-share go-private proposal, not subject to financing conditions

• Proposal covers all Definitive Healthcare shares Advent International does not already own and is entirely all-cash.
• Proposal assumes founder Jason Krantz will roll over his equity into the post-transaction company.
• Board appoints Clay Ritchey as next CEO and director, succeeding Kevin Coop, effective September 8, 2026.

https://finviz.com/stock?t=DH&p=d